The Merger and Acquisition in the Blood Products Sector after Covid-19: A Study on the Deals of China’s Enterprises

After COVID-19, the demand for blood products such as IVIG roared up immediately. Global biopharmaceutical enterprises are in a wave of M&As for expansion. While there lacks of related research on China’s blood products sector. This article takes the example of financial data from Grifols and Ch...

Full description

Saved in:
Bibliographic Details
Main Author: Wang Maobang
Format: Article
Language:English
Published: EDP Sciences 2024-01-01
Series:SHS Web of Conferences
Online Access:https://www.shs-conferences.org/articles/shsconf/pdf/2024/27/shsconf_icdeba2024_01024.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!